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Abstract
Background: Chronic wounds affect millions of people and cost billions of dollars in the United States each year.
These wounds harbor polymicrobial biofilm communities, which can be difficult to elucidate using culturing
methods. Clinical molecular microbiological methods are increasingly being employed to investigate the microbiota
of chronic infections, including wounds, as part of standard patient care. However, molecular testing is more
sensitive than culturing, which results in markedly different results being reported to clinicians. This study compares
the results of aerobic culturing and molecular testing (culture-free 16S ribosomal DNA sequencing), and it examines
the relative abundance score that is generated by the molecular test and the usefulness of the relative abundance
score in predicting the likelihood that the same organism would be detected by culture.
Methods: Parallel samples from 51 chronic wounds were studied using aerobic culturing and 16S DNA sequencing
for the identification of bacteria.
Results: One hundred forty-five (145) unique genera were identified using molecular methods, and 68 of these
genera were aerotolerant. Fourteen (14) unique genera were identified using aerobic culture methods. One-third
(31/92) of the cultures were determined to be < 1% of the relative abundance of the wound microbiota using
molecular testing. At the genus level, molecular testing identified 85% (78/92) of the bacteria that were identified
by culture. Conversely, culturing detected 15.7% (78/497) of the aerotolerant bacteria and detected 54.9% of the
collective aerotolerant relative abundance of the samples. Aerotolerant bacterial genera (and individual species
including Staphylococcus aureus, Pseudomonas aeruginosa, and Enterococcus faecalis) with higher relative abundance
scores were more likely to be detected by culture as demonstrated with regression modeling.
Conclusion: Discordance between molecular and culture testing is often observed. However, culture-free 16S
ribosomal DNA sequencing and its relative abundance score can provide clinicians with insight into which bacteria
are most abundant in a sample and which are most likely to be detected by culture.
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Background
Chronic wounds impact the health of over 8 million
people in the United States each year, and the direct
healthcare associated cost of these wounds is over 25
billion of dollars each year [1]. These chronic wounds
include venous stasis ulcers, diabetic foot ulcers, decubi-
tus ulcers, and non-healing surgical wounds. Medicine
has worked to address the many barriers to healing in-
cluding repetitive trauma, poor nutrition, impaired host
defense, and infection. The presence of bacterial biofilms
in chronic wounds has been established [2], and wound
care clinicians attempt to manage these bacteria in
chronic wounds [3]. In this study, we examine the bac-
terial components of the wound bioburden using two
clinical laboratory tests: traditional aerobic culturing and
recently developed culture-free sequencing of bacterial
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Previous studies have compared culturing to molecular
methods [2,4-10], and we have performed studies to com-
pare culturing to the molecular testing method we use in
this study [2,9]. These studies agree that molecular micro-
bial tests are more sensitive than culture testing and hold
promise for improving patient care. The current study
adds to this body of work. The molecular test used in
this study produces a relative abundance score, and we
describe the relevance of this score and the correlation it
has to culture results.
Providing more accurate information to the clinician via
more sensitive testing is typically the goal of the clinical
microbiology laboratory. More sensitive microbial testing,
such as culture-free sequencing of bacterial DNA that is
used in this study, can identify numerous microbial taxa
in a single clinical sample. Unfortunately, the clinician can
have difficulty discerning which bacteria could be most
clinically relevant. Being able to correlate the results of
this newer testing method with a familiar testing method
(culturing) would be helpful for the clinician. Culture-
free sequencing of bacterial DNA reveals qualitatively
which bacteria are present, but it also reports a relative
abundance score for each organism. Correlating this rela-
tive abundance score with the likelihood that the same
bacterium would be detected by culture has not been
performed until now. Correlating the results of molecular
microbial diagnostic tests with the results from culturing
will give clinicians insight into understanding these new
tests and their clinical relevance. Improving clinicians’
ability to interpret test results will enable them to better
customize their patient care and overcome each individual
patient’s barriers to healing.
Methods
In this study, the chronic wounds from 51 subjects were
sampled for study in accordance with Western Institutional
Review Board protocol #20062347. All subjects signed
informed consent documents. All samples were obtained at
the Southwest Regional Wound Care Center (Lubbock,
Texas) in 2009. Types of wounds included chronic wounds
such as venous stasis ulcers, diabetic foot ulcers, pressure
ulcers, and non-healing surgical wounds. Each sample of
devitalized tissue was obtained using sharp debridement as
part of standard of care. Each chronic wound site was
sampled in duplicate for parallel testing. One portion was
analyzed by culture in an academic, hospital-based micro-
biology laboratory while the other portion was analyzed by
molecular methods at PathoGenius laboratory (Lubbock,
Texas). Both labs are accredited by the College of American
Pathologists.
Criteria for inclusion and exclusion
Fifty-one (51) consecutive subjects that presented to the
Southwest Regional Wound Care Center with full thickness
wounds (e.g. venous stasis ulcers, diabetic foot ulcers,
decubitus ulcers, and non-healing surgical wounds) were
included in the study if they had a chronic wound as
defined as a wound that fails to progress through normal
wound healing trajectory, if sharp debridement was
required as part of their standard of care, and if enough de-
bridement material was obtained in order to perform both
culture and molecular testing.
Sample collection and processing
Cultures were obtained as per laboratory protocol. Samples
from the host-bioburden interface were obtained at the
Southwest Regional Wound Care Center and transported
to the hospital microbiology laboratory for aerobic culture
and identification. Some of the isolated bacteria were then
analyzed by the Research & Testing Laboratory (Lubbock,
Texas, USA) to verify the isolates’ identities using molecular
testing. A second, parallel sample was obtained and placed
in a 2 mL microcentrifuge tube and tested by Pathogenius
(Lubbock, Texas, USA).
16S Ribosomal DNA (rDNA) processing & analysis
The methods have been thoroughly described previously
[9]. Briefly, DNA was extracted from the samples, and
the 16S portion of ribosomal DNA was amplified. The
16S amplicons were then pyrosequenced using Roche’s
(formerly 454’s) FLX Titanium technology, and sequences
were queried against a taxonomic database of high quality
sequences derived from NCBI using BLASTN+. Sequences
with identity scores to well characterized 16S sequences
greater than 97% identity (<3% divergence) were resolved at
the species level, between 95% and 97% at the genus level.
Determining the contribution of each bacterial taxon to
the wound microbiota
The total number of sequence matches for an organism
in each sample was considered 100% of the relative
abundance for that sample. Most of the analysis was per-
formed at the genus level, but some analysis was also
performed at the species level (Staphylococcus aureus,
Pseudomonas aeruginosa, Enterococcus faecalis). Each
detected taxon comprised a percentage of the total rela-
tive abundance in the sample. For some of the analyses,
these percentages were divided into three categories
based upon the frequency of taxon detection. Taxa with
a relative abundance of more than 10% were considered
to be “Dominant” contributors to the sampled micro-
biota. Taxa with relative abundance of 1-10% were
considered to be “Major” contributors to the sampled
bacterial population, and taxa with relative abundance of
less than 1% were considered to be “Minor” components
of the bacterial population in the wound. This arbitrary
scoring system was employed to the genera within the
dataset.
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Cross-checking of culture and molecular results
Research & Testing Laboratory (Lubbock, Texas) was used
to cross-check the culture isolates using molecular testing.
The clinical microbiology laboratory provided cultured
isolates to the research laboratory for verification of iden-
tification. The research laboratory extracted 16S DNA
and sequenced a portion of the gene to determine each
isolate’s species. The bacterial species determined by
molecular testing in the research laboratory was then
compared to the clinical laboratory’s identification of the
isolate.
Statistical methods
The combined microbiome of all samples was illustrated
using a rank-abundance plot. This plots each genus’ rela-
tive abundance (assessed via molecular methods) as a
function of its rank within the entire community, and
graphically illustrates the overall diversity of the wound
microbiome. The relationship between the likelihood of
a bacterium being cultured and its relative abundance
was graphically illustrated using a mosaic plot and was
statistically evaluated using logistic regression. Specific-
ally, we used a generalized linear model that assumed a
binomial error distribution and a logit link function.
Significance of the relationship was assessed using a like-
lihood ratio test, and results are reported as an odds
ratio with a 95% confidence interval. The odds ratio is a
measure of the increase in the odds of being detected
via culture based methods given an increase in relative
abundance. Statistical analyses were conducted in R [9].
Results & discussion
Like previous studies, this study demonstrates that cul-
ture testing and molecular testing of wound bacteria
produce differing and often conflicting results because
molecular methods are more sensitive than culture
methods [7-10]. The current study demonstrates that it
is important to consider the relative abundance of the
bacteria that are detected by the molecular test used in
this study and not only the qualitative results of the test.
The relative abundance of the bacterial species within
the sample helps to predict the likelihood that the spe-
cies will be detected by culture. That is, bacteria with
greater relative abundance within a wound sample are
more likely to be cultured than other bacteria with less
relative abundance. These findings are different from
what has been previously reported in a study using a dif-
ferent molecular method of analysis (fluorescent in situ
hybridization), which reported, “the absence of a correl-
ation between the bacterial species [Staphylococcus aureus
and Pseudomonas aeruginosa] detected in wound by cul-
ture and what is in fact present” [5].
In the current study, 51 samples were cultured, and 93
isolates were identified. One sample yielded two species
from the same genus, so 92 genus-level taxa were identi-
fied in the 51 samples. An average of 1.8 ± 0.9 bacterial
genera were identified in each sample (Table 1), repre-
senting 14 unique genera in total. Staphylococcus and
Enterococcus comprised the majority of the detected
genera; they were detected 28 and 21 times, respectively.
When considering only the 92 detected genera, 16S
DNA sequencing identified the same genus in the sam-
ple 78 times. Of those 78 times, the bacterial population
was determined to be a dominant population (>10% of
the wound microbiota relative abundance) 43 times, a
major population (1-10% of the wound microbiota rela-
tive abundance) 18 times, and a minor population (<1%
of the wound microbiota relative abundance) 17 times.
Fourteen (14) times, the bacterial genus identified by
culture was not detected by molecular testing. It is pos-
sible that some of the 14 bacterial genera that were iden-
tified by culture but not identified by 16S testing may
have been misidentified by one of the testing methods
(Table 2). Genetic testing is the gold standard for species
identification, so if one of the tests misidentified an or-
ganism, it is most likely that culturing misidentified the
organism. Another possibility is that deeper 16S DNA
sequencing would have revealed the genera that were
identified by culture.
16S sequencing methods resulted in an average of
2411 sequences per sample, with the average read length
for all samples being 466 bases. From these sequences,
Table 1 Comparison of the number of bacterial taxa
detected using molecular testing and culturing testing
Mean STD Min Max
16S Testing for All Bacterial Genera
All Genera 14.8 7.5 3 38
Dominant Genera 2.2 1.1 1 5
Major Genera 3.7 3.7 0 16
Minor Genera 8.9 5.7 0 26
16S Testing for Aerotolerant Bacterial Genera
All Genera 9.8 5.3 2 29
Dominant Genera 1.8 0.9 0 4
Major Genera 2.4 2.3 0 10
Minor Genera 5.6 4.4 0 19
Bacterial Genera Detected by Aerobic Culture
All Genera 1.8 0.9 1 5
The number of bacterial genera identified using molecular testing and the
number of bacterial genera cultured using aerobic testing of the 51 samples
are listed. The mean number of genera identified using molecular
identification or isolates identified using culture identification are listed.
Molecular testing results are listed for both 1) all bacterial genera and for
2) only aerotolerant bacterial genera. The standard deviation (STD), minimum
number of genera (Min), and the maximum number of genera (Max) are also
listed. These same data were determined for subsets of genera determined to
be present at >10% of the relative abundance in the sample (Dominant),
1-10% of the relative abundance in the sample (Major), and less than 1% of
the relative abundance in the sample (Minor).
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753 bacterial taxa (genera) were detected (average num-
ber per sample, 14.8 ± 7.5), and these 753 positive results
were found within 145 unique genera (Figure 1, Table 1,
and Additional file 1). Forty-seven percent (47%; 68/145)
of the unique genera were aerotolerant and potentially
culturable using aerobic culture methods. Sixty-six per-
cent (66% ; 497/753) of the positive results were attribu-
ted to the 68 aerotolerant genera (average per sample
9.8 ± 5.3), and these were the bacteria considered in
most of the analyses. Sequence analysis identified 18%
(91/497) of the bacteria as dominant components of the
population, 24% (120/497) as major components to the
population, and 58% (286/497) as minor components of
the population. Aerobic culturing detected 15.7% (78/497)
of the potentially culturable organisms. Cultures identified
dominant genera 47% (43/91) of the time, major genera
15% (18/120) of the time, and minor genera 5.9% (17/286)
of the time (Figure 2).
It can be argued that the 58% (286/497) of results
attributed to bacteria that occurred with less than 1%
relative abundance in their samples were environmental
contaminants within the wounds. If this is the case, it is
important to note that 18% (17/92) of the bacteria that
were isolated by culture were in this group, so culturing
also detects bacteria that may be environmental con-
taminants. Another 15% (14/92) of the cultured bacteria
were not detected at all using molecular methods, which
could be because of very low levels of the bacteria within
the wound. In total, one-third (31/92) of the genera
detected by culture were either not detected using 16S
sequencing or detected to be present at less than 1% of
the relative abundance within the sample. The clinical
usefulness of attempting to manage bacteria present at
such low abundance within a sample is questionable.
The molecular testing results suggest that culture testing
may be insufficiently sensitive in some cases or overly
sensitive in other cases. Therefore, careful clinical inter-
pretation of culture results is necessary [11,12].
Some bacteria were more commonly detected by culture
than others (Table 3). In some instances, this variation in
detection can be attributed to the relative abundance of
the bacteria in the original sample (Figures 2, 3, & 4), but
detection also depends upon the type of bacteria. For
example, culturing identified Staphylococcus in 61% (28/
46) of the samples that were positive by molecular testing
(average relative abundance of 28% per sample), but
Corynebacterium was only identified by culture in 16%
(6/38) of the samples that were positive by molecular
Table 2 Discrepant results between bacterial isolate
identification by phenotype and isolate identification
by genotype
Phenotypic Identification Genetic Identification
Enterobacter cloacae Escherichia coli
Pseudomonas aeruginosa Salmonella enterica
Staphylococcus spp. Enterococcus faecalis
Coagulase Negative Staphylococci Enterococcus faecalis
Aeromonas hydrophila Aeromonas punctata
Citrobacter freundii Citrobacter murliniae
Enterococcus raffinosus Enterococcus avium
Enterococcus raffinosus Enterococcus avium
Staphylococcus intermedius Staphylococcus pseudintermedius
Of the 46 cultured bacterial isolates that were cross-checked using DNA
testing to verify identification, discrepancies in the identification of the isolate
were present 9 times. The 9 discrepant isolates are listed above. The
biochemically-determined taxonomic classification determined by culture
phenotype is in the left column, and the molecularly-determined species
classification by DNA 16S analysis is in the right column.
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Figure 1 Frequently identified bacteria genera. Rank abundance distribution of the 145 bacterial genera detected by 16S DNA sequencing
methods. Here, abundance is based on the sum of relative abundances from all samples. Red dots represent genera that were cultured
aerobically. Only the 14 most abundant genera are labeled.
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testing (average relative abundance of 24% per sample).
Both the organism and its relative abundance affect the
ability to detect the organism by culture.
Many of the bacteria that were identified by culture
contributed to a large portion of the relative abundance
of bacteria in the samples, but about half of the bacteria
that were determined to comprise a dominant portion of
the microbiota were not detected by culture (Figure 2).
Some of the uncultured bacteria were obligate anaerobes
(Figure 1 & Table 3), and the culture of obligate anae-
robes was not attempted in this study because anaerobic
cultures were not part of the patients’ standard of care.
Obligate anaerobic bacteria were frequently identified by
molecular testing, but they comprised an average of only
15.5% of the relative abundance in each sample. Previous
studies have established that obligate anaerobes are im-
portant but difficult to detect in chronic wounds [2,13].
In this study, molecular testing identified an average of
84.5% (±27.5%) of the relative abundance of the bacteria
as aerotolerant, but many of these bacteria were faculta-
tive anaerobes and may have been growing in anaerobic
conditions.
In general, the likelihood of an organism being cul-
tured was positively related to its relative abundance
(Figure 3). This trend was evident when all aerotolerant
genera were examined together (OR = 1.05, 95% CI 1.04-
1.07). Culturing detected 54.9% of the relative abundance
(as determined by 16S sequencing) of the potentially cul-
turable bacteria, and the remaining 45.1% of the relative
abundance went undetected by culturing.
Similar results were identified at the species level: spe-
cies with a higher relative abundance in the sample as
determined by molecular testing were more likely to be
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Figure 2 Relative abundance of wound bacteria influences their
likelihood of culture detection. Mosaic plot of the number of
times a detected bacterial genus (as determined by molecular
methods) was cultured (as shown in gray). Only aerobic bacteria
were considered, and bacterial genera were divided into dominant
(>10%), major (1-10%), or minor (<1%) components of each sample
based upon their relative abundance within each sample. Areas of
each component of the plot are proportional to the observed
number of occurrences. Dominant genera were cultured 47%
(43/91) of the time. Major genera were cultured 15% (18/120) of the
time. Minor genera were cultured 5.9% (17/286) of the time.
Table 3 Comparison of the frequently identified bacterial
genera detected by molecular and culture testing
16S DNA Sequencing Culture
Samples Genus Samples Genus
46 Staphylococcus* 28 Staphylococcus*
38 Corynebacterium* 21 Enterococcus*
32 Pseudomonas* 8 Pseudomonas*
31 Clostridium† 8 Serratia*
28 Bacillus* 7 Proteus
27 Enterococcus* 6 Corynebacterium*
26 Paenibacillus 4 Enterobacter*
22 Serratia* 2 Citrobacter*
22 Propionibacterium† 2 Escherichia*
20 Escherichia* 2 Streptococcus*
20 Streptococcus* 1 Acinetobacter*
19 Brevibacterium 1 Aeromonas
17 Citrobacter* 1 Bacillus*
17 Klebsiella* 1 Klebsiella*
17 Lactobacillus
17 Finegoldia†
15 Sarcina†
13 Anaerococcus†
11 Bacteroides†
11 Peptoniphilus†
11 Prevotella†
10 Enterobacter*
10 Salmonella
9 Providencia
9 Peptostreptococcus†
8 Acinetobacter*
8 Nocardiopsis
Of the 145 genera identified by 16S sequencing in the 51 samples in this
study, the 27 most frequently identified genera are included in the table. Nine
(9) of these 27 genera are obligate anaerobes, and culture did not attempt to
detect these organisms. All 14 of the bacterial genera identified by culture are
included in the table. The two bacteria detected by culture and not listed in
the “16S DNA Sequencing” column of the table are Proteus and Aeromonas,
which were detected using 16S sequencing 6 and 1 times, respectively. The
frequency of identification of each genus is noted under the “Samples”
heading.
* Genus present in both columns.
† Obligate anaerobic genus.
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cultured (Figure 4). Three species were examined. The
trend was significantly positive for Pseudomonas aeruginosa
(OR = 1.17; 95% CI, 1.08-1.31) and Staphylococcus aureus
(OR = 1.08; 95% CI, 1.03-1.15), and approached significance
for Enterococcus faecalis (OR = 1.05; 95% CI, 0.98-1.16).
Exhaustively culturing all of the bacteria within a clin-
ical sample has proven difficult [8,10,14]. Detecting the
presence of anaerobes can be especially cumbersome,
and anaerobes routinely are not identified, even though
anaerobes are common contributors to the sample
[8,13,14]. Additionally, many chronic infections include
biofilms with dormant bacteria (viable but non-culturable
[VBNC]), which are inherently difficult to culture [2,15].
Culturing from a mixed sample of bacteria, which is com-
mon in clinical wound samples, results in culture bias
where some bacteria are positively selected because they
grow quickly and robustly in the culture media, but fas-
tidious organisms can be negatively selected and may
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Figure 3 Increased relative abundance of a bacterial genus increases the likelihood that the genus will be cultured. Each dot represents
the detection of a bacterial genus by 16S DNA sequencing. Genera that were detected by culture (response = 1) are represented by dots at the
top of the figure, and genera that were not cultured (response = 0) are represented as dots at the bottom of the figure. The proportion of
occurrences that were detected by culture was modeled as a function of the observed relative abundance (as determined using molecular
testing) using logistic regression (indicated by the blue line). The results demonstrate that an increased relative abundance of a bacterial genus
subsequently increases the likelihood that the genus will be cultured. The shaded region indicates the 95% confidence interval of the predicted
proportion.
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Figure 4 Increased relative abundance of a bacterial species increases the likelihood that the species will be cultured. Each dot
represents the detection of the species by 16S deep sequencing. Species that were detected by culture (response = 1) are represented by dots at
the top of the figure, and species that were not cultured (response = 0) are represented as dots at the bottom of the figure. The proportion of
occurrences that were detected by culture was modeled as a function of the observed relative abundance (as determined using molecular
testing) using logistic regression (indicated by the blue line). The shaded region indicates the 95% confidence interval of the predicted
proportion. The trend was significantly positive for Pseudomonas aeruginosa (OR = 1.17; 95% CI, 1.08-1.31) and Staphylococcus aureus
(OR = 1.08; 95% CI, 1.03-1.15), and it approached significance for Enterococcus faecalis (OR = 1.05; 95% CI, 0.98-1.16). The results demonstrate that
an increased relative abundance of one of these species within a sample subsequently increases the likelihood that the species will be cultured.
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grow more slowly or not at all. Therefore, using standard
culture results to extrapolate the relative or absolute
quantity of a bacterial species that was present within the
original sample should not be performed because this
method is unreliable (Figure 2).
Molecular methods can overcome some of cultures’
shortcomings. Molecular testing can detect biofilm bac-
teria, anaerobes, and VBNC bacteria regardless of how
well the bacteria may or may not grow in culture [10,12].
Molecular methods can be designed to examine these
organisms quantitatively, and, unlike culture testing, the
presence of antibiotics within the sample does not inter-
fere with the testing sensitivity. Molecular methods can
elucidate the presence of bacteria regardless of whether or
not the bacteria can be cultured.
Forty-six (46) culture isolates were cross-checked for
identification using molecular methods, and discrepan-
cies were observed in 20% (9/46) of the isolates (Table 2):
4 genus-level discrepancies and 5 species-level discrep-
ancies. Of the 46 isolates, 43 were identified to species
and 3 were only identified to genus. The 5 species-level
discrepancies were arguably clinically insignificant. The
four genus-level discrepancies were more clinically sig-
nificant. Twice, biochemical testing determined isolates
were staphylococci, but molecular testing determined the
isolates were enterococci. Once, P. aeruginosa was identi-
fied by culture, but Salmonella enterica was identified by
molecular testing. As mentioned previously, identification
of bacteria by genotype is considered superior to the iden-
tification of bacteria by phenotype, so culture testing
reported significant misidentifications of bacterial taxa 7%
(3/46) of the time.
Limitations of this study include the small size of the
sample population, the lack of anaerobic bacterial cultures,
and the difficulty of replicating this study at other labora-
tories. Only 51 subjects were examined in this study,
which was large enough to recognize statistically signifi-
cant trends, but studies that analyze more samples should
be performed. Anaerobic cultures were not obtained as
this was a standard of care study. Many wound care
specialists do not routinely request anaerobic cultures be-
cause the cost is significant, and organisms are rarely
recovered. The molecular methods employed by in this
study are available in very few clinical testing laboratories
because of the high initial set-up costs and the large
amount of data analysis that is required, which makes
repeating this study at other institutions difficult.
The authors have performed previous studies to exam-
ine the clinical outcomes of patients when using molecular
microbial diagnostic testing and have reported improve-
ment in patient outcomes when using molecular testing
when compared to when culture testing was used [16,17].
The current study may help to explain why this improve-
ment was observed. Culture-free 16S DNA sequencing
detects more of the bacterial components of the wound
microbiota, and it is able to determine the relative
abundance scores of the bacteria comprising the polymi-
crobial infection. The increased sensitivity and the relative
abundance scores are helpful in guiding clinical decision
making. It is appropriate to perform prospective studies
that compare culture and molecular methods of bacterial
identification and their impact on clinical decision making
and patient outcome.
Conclusion
This study suggests that bacteria with higher relative
abundance scores (as determined by molecular testing)
are more likely to be detected by culture, and bacteria
with lower relative abundance scores are less likely to be
detected by culture. Culture testing is not as sensitive as
molecular testing, so culturing often fails to detect
bacteria, even bacteria that are present in a high relative
abundance. Bacteria that are present in high relative
abundance are likely of high clinical relevance, including
the bacteria that are not detected by culture. By consid-
ering the relative abundance scores when interpreting
molecular results, clinicians can gain a clearer picture as
to which bacteria may be most clinically relevant.
Prospective studies comparing patient and wound out-
comes when using culture testing versus molecular
microbial testing have not yet been performed, but
retrospective studies suggest molecular microbial testing
can improve patient outcomes [16,17].
Additional file
Additional file 1: Bacteria identified by 16S and culture testing
according to each subject.
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